This study investigates how different types of infant feedings, such as breast milk and infant formula, impact growth and lung health in infants diagnosed with cystic fibrosis (CF). Cystic fibrosis is a genetic disorder that affects the lungs and digestive system, leading to severe respiratory and nutritional challenges.
Participants in the study will be observed to determine how their growth and lung function respond to their specific feeding regimen. This involves regular assessments of health indicators related to their diet and respiratory health.
- Who can participate: Infants diagnosed with cystic fibrosis are eligible to participate. Participants should be below 12 months of age. Additional eligibility factors include a confirmed diagnosis of cystic fibrosis and no prior participation in similar feeding studies.
- Study details: Participants will be monitored to assess the impact of their feeding regimen on health outcomes. This will involve regular health assessments.
